Literature DB >> 14572882

Impaired nitric oxide synthase-dependent dilatation of cerebral arterioles in type II diabetic rats.

RoseAnn M Schwaninger1, Hong Sun, William G Mayhan.   

Abstract

The goals of this study were to determine the effects of type II diabetes mellitus on nitric oxide synthase-dependent responses of cerebral arterioles and on endothelial nitric oxide synthase (eNOS) protein in cerebral arterioles. We examined dilatation of cerebral (pial) arterioles in 13-15 week old male lean and diabetic obese Zucker rats in response to nitric oxide synthase-dependent agonists (acetylcholine and adenosine diphosphate (ADP)) and a nitric oxide synthase-independent agonist (nitroglycerin). We found that acetylcholine (10 microM) increased cerebral arteriolar diameter by 10 +/- 3% (mean +/- SE) in lean Zucker rats, but by only 2 +/- 2% in diabetic obese Zucker rats (p<0.05). In addition, ADP (100 microM) increased cerebral arteriolar diameter by 20 +/- 2% in lean Zucker rats, but by only 8 +/- 2% in diabetic obese Zucker rats (p<0.05). In contrast, nitroglycerin produced similar vasodilatation in lean and diabetic obese Zucker rats. Thus, impaired dilatation of cerebral arterioles in diabetic obese Zucker rats is not related to non-specific impairment of vasodilatation. Following these functional studies, we harvested cerebral microvessels for Western blot analysis of eNOS protein. We found that eNOS protein was significantly higher in diabetic obese Zucker rats than in lean Zucker rats (p<0.05). Thus, type II diabetes mellitus impairs nitric oxide synthase-dependent responses of cerebral arterioles. In addition, eNOS protein from cerebral blood vessels is increased in diabetic obese Zucker rats.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14572882     DOI: 10.1016/j.lfs.2003.06.029

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  9 in total

Review 1.  Cerebrovascular complications of diabetes: focus on stroke.

Authors:  Adviye Ergul; Aisha Kelly-Cobbs; Maha Abdalla; Susan C Fagan
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2012-06       Impact factor: 2.895

Review 2.  The effects of obesity on the cerebral vasculature.

Authors:  Anne M Dorrance; Nusrat Matin; Paulo W Pires
Journal:  Curr Vasc Pharmacol       Date:  2014-05       Impact factor: 2.719

3.  Chronic resveratrol treatment restores vascular responsiveness of cerebral arterioles in type 1 diabetic rats.

Authors:  Denise M Arrick; Hong Sun; Kaushik P Patel; William G Mayhan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-06-10       Impact factor: 4.733

4.  Comparison of selective versus dual endothelin receptor antagonism on cerebrovascular dysfunction in diabetes.

Authors:  Weiguo Li; Kamakshi Sachidanandam; Adviye Ergul
Journal:  Neurol Res       Date:  2011-03       Impact factor: 2.448

5.  Effect of chronic endothelin receptor antagonism on cerebrovascular function in type 2 diabetes.

Authors:  Alex K Harris; Mostafa M Elgebaly; Weiguo Li; Kamakshi Sachidanandam; Adviye Ergul
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-02-20       Impact factor: 3.619

6.  Effect of chronic and selective endothelin receptor antagonism on microvascular function in type 2 diabetes.

Authors:  Kamakshi Sachidanandam; Mostafa M Elgebaly; Alex K Harris; Jim R Hutchinson; Erin M Mezzetti; Vera Portik-Dobos; Adviye Ergul
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-04-18       Impact factor: 4.733

7.  Obesity increases blood pressure, cerebral vascular remodeling, and severity of stroke in the Zucker rat.

Authors:  Jessica M Osmond; James D Mintz; Brian Dalton; David W Stepp
Journal:  Hypertension       Date:  2008-12-22       Impact factor: 10.190

8.  Cerebral myogenic reactivity and blood flow in type 2 diabetic rats: role of peroxynitrite in hypoxia-mediated loss of myogenic tone.

Authors:  Aisha I Kelly-Cobbs; Roshini Prakash; Maha Coucha; Robert A Knight; Weiguo Li; Safia N Ogbi; Maribeth Johnson; Adviye Ergul
Journal:  J Pharmacol Exp Ther       Date:  2012-05-08       Impact factor: 4.030

9.  Telmisartan prevents high-fat diet-induced neurovascular impairments and reduces anxiety-like behavior.

Authors:  Gianna Huber; Mikolaj Ogrodnik; Jan Wenzel; Ines Stölting; Lukas Huber; Olga Will; Eva Peschke; Urte Matschl; Jan-Bernd Hövener; Markus Schwaninger; Diana Jurk; Walter Raasch
Journal:  J Cereb Blood Flow Metab       Date:  2021-03-17       Impact factor: 6.200

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.